Skip to main content

Great Debates in Gastrointestinal Cancers Basic Listing

Great Debates in
Gastrointestinal Cancers

Rutika Mehta, MD, MPH, Weill Cornell Medicine
Videos
09/17/2025
Rutika Mehta, MD, MPH
Rutika Mehta, MD, MPH, discusses how to optimize supportive care for patients with gastrointestinal cancers.
Rutika Mehta, MD, MPH, discusses how to optimize supportive care for patients with gastrointestinal cancers.
Rutika Mehta, MD, MPH, discusses...
09/17/2025
Oncology
Olatunji Alese, MD, Winship Cancer Center
Videos
09/17/2025
O. Alese
Olatunji Alese, MD, discusses the use of dual immune checkpoint blockade, for frontline therapy and sequencing, for patients with advanced hepatocellular carcinoma.
Olatunji Alese, MD, discusses the use of dual immune checkpoint blockade, for frontline therapy and sequencing, for patients with advanced hepatocellular carcinoma.
Olatunji Alese, MD, discusses...
09/17/2025
Oncology
William Grady, MD
Conference Coverage
03/27/2025
William Grady, MD
William Grady, MD, compares biomarker-based testing and colonoscopy when considering options for colorectal cancer screening.
William Grady, MD, compares biomarker-based testing and colonoscopy when considering options for colorectal cancer screening.
William Grady, MD, compares...
03/27/2025
Oncology
Reid Ness, MD, MPH
Conference Coverage
03/27/2025
Reid Ness, MD
Reid Ness, MD, MPH, discusses the nordICC trial, which assessed the efficacy of using colonoscopy as a primary screening tool.
Reid Ness, MD, MPH, discusses the nordICC trial, which assessed the efficacy of using colonoscopy as a primary screening tool.
Reid Ness, MD, MPH, discusses...
03/27/2025
Oncology
Reid Ness, MD, MPH
Conference Coverage
03/27/2025
Reid Ness, MD
Reid Ness, MD, MPH, argues that colonoscopy is superior compared to biomarker-based testing for the detection of colorectal cancer.
Reid Ness, MD, MPH, argues that colonoscopy is superior compared to biomarker-based testing for the detection of colorectal cancer.
Reid Ness, MD, MPH, argues that...
03/27/2025
Oncology
Raghav Sundar, MD, PhD, Yale Cancer Center
Videos
03/27/2025
Raghav Sundar, MD
Raghav Sundar, MD, PhD, discusses the importance of considering tumor biology and anatomic site when determining treatments for patients with gastrointestinal cancers.
Raghav Sundar, MD, PhD, discusses the importance of considering tumor biology and anatomic site when determining treatments for patients with gastrointestinal cancers.
Raghav Sundar, MD, PhD,...
03/27/2025
Oncology
Richard Finn, MD
Conference Coverage
03/25/2025
Richard Finn, MD, assesses the use of dual checkpoint inhibition in the first-line setting for patients with advanced hepatocellular carcinoma.
Richard Finn, MD, assesses the use of dual checkpoint inhibition in the first-line setting for patients with advanced hepatocellular carcinoma.
Richard Finn, MD, assesses the...
03/25/2025
Oncology
James Harding, MD
Conference Coverage
03/25/2025
James J. Harding
James Harding, MD, discusses advantages associated with combining VEGF inhibitors and immune checkpoint inhibition in the first-line setting for patients with advanced hepatocellular carcinoma.
James Harding, MD, discusses advantages associated with combining VEGF inhibitors and immune checkpoint inhibition in the first-line setting for patients with advanced hepatocellular carcinoma.
James Harding, MD, discusses...
03/25/2025
Oncology
News
03/19/2025
The best of HMP Global’s three Great Debates programs will be featured in one 2025 series, Great Debates in Solid Tumors, delivering a more comprehensive learning experience for oncology clinicians in the gastrointestinal, women’s and lung...
The best of HMP Global’s three Great Debates programs will be featured in one 2025 series, Great Debates in Solid Tumors, delivering a more comprehensive learning experience for oncology clinicians in the gastrointestinal, women’s and lung...
The best of HMP Global’s three...
03/19/2025
Oncology